2 results match your criteria: "Pharma Center Vienna[Affiliation]"
Eur J Pharm Biopharm
November 2003
Institute of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Pharma Center Vienna, Vienna, Austria.
Silver nanoparticle enhanced fluorescence is introduced as an alternative method to surface plasmon resonance techniques for real time monitoring of biorecognitive interactions or immunoassays. This method relies on the phenomenon that an electromagnetic near field is generated upon illumination on the surface of silver nanoparticles. The interaction of this field with nearby fluorophores results in fluorescence enhancement.
View Article and Find Full Text PDFInt J Pharm
April 2003
Institute of Pharmaceutical Technology and Biopharmaceutics, Pharma Center Vienna, Althanstrasse 14, A-1090, Vienna, Austria.
The preservation of biological activity of protein drugs in formulations is still a major challenge for successful drug delivery. The enzyme L-asparaginase, which exhibits a short in vivo half-life and is only active against leukaemia in its tetrameric form, was encapsulated in poly(D,L-lactide-co-glycolide) nanospheres by the (w/o)/w-emulsion solvent evaporation technique in presence of various potential stabilisers. Elucidation of the preparation steps revealed that the enzyme is denaturated at the aqueous/organic interface and by sonication.
View Article and Find Full Text PDF